clinical trial · NCT03665038
A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)
Post Partum DepressionBrexanolone
brief summary
This is a multi-center study evaluating the safety, tolerability, and pharmacokinetics of brexanolone in the treatment of adolescent female participants with postpartum depression (PPD).
started
Sep 7, 2018
primary completion
Jan 8, 2021
completion
Jan 8, 2021
last updated
Sep 15, 2025
official title
A Multicenter, Open-Label Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Brexanolone in the Treatment of Adolescent Female Subjects With Postpartum Depression
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol